Immunitybio, Inc. · NASDAQ:IBRX
Immunitybio, Inc. shareholders
As of Jun 30, 2026, 394 institutions reported holding Immunitybio, Inc., 19.1% of its shares. Largest: Vanguard, BlackRock and State Street. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Immunitybio, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 36.5M | 3.4% | +2.43M | Aug 13, 2026 |
| BlackRock | 34.1M | 3.2% | +7.74M | Aug 7, 2026 |
| State Street | 21.4M | 2.0% | +3.69M | Aug 7, 2026 |
| D. E. Shaw & Co., Inc. | 11.6M | 1.1% | −1.02M | Aug 14, 2026 |
| Two Sigma | 11.1M | 1.0% | +6.71M | Aug 14, 2026 |
| Geode Capital | 9.85M | 0.93% | +1.82M | Aug 12, 2026 |
| Millennium | 5.58M | 0.53% | +4.16M | Aug 14, 2026 |
| UBS | 3.73M | 0.35% | +250K | Aug 13, 2026 |
| Northern Trust | 3.57M | 0.34% | +1.06M | Aug 13, 2026 |
| Morgan Stanley | 3.43M | 0.32% | −586K | Aug 13, 2026 |